| |
| |
|
| Insider
Information: |
Daniell Richard |
| Relationship: |
|
| City: |
Petach Tikva |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
98,943 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,690,936 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
98,943 |
|
|
| Total
Value |
$1,690,936 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Teva Pharmaceutical Industries L... |
TEVA |
|
2024-03-05 |
98,943 |
2018-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,098 |
2,098 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2018-03-05 |
4 |
D |
$19.28 |
$19,087 |
D/D |
(990) |
1,108 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2018-03-05 |
4 |
S |
$19.28 |
$21,362 |
D/D |
(1,108) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2018-03-12 |
4 |
S |
$19.50 |
$13,922 |
D/D |
(714) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2018-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
714 |
714 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2018-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,297 |
1,297 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2018-03-19 |
4 |
S |
$17.89 |
$23,206 |
D/D |
(1,297) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2018-09-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
696 |
696 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2018-09-10 |
4 |
S |
$21.25 |
$14,790 |
D/D |
(696) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2018-09-18 |
4 |
S |
$23.69 |
$58,943 |
D/D |
(2,488) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2018-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,488 |
2,488 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2019-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,098 |
2,098 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2019-03-04 |
4 |
S |
$16.88 |
$35,423 |
D/D |
(2,098) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2019-03-12 |
4 |
S |
$15.69 |
$11,218 |
D/D |
(715) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2019-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
715 |
715 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2019-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,297 |
1,297 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2019-03-18 |
4 |
S |
$16.64 |
$21,588 |
D/D |
(1,297) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2019-09-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
696 |
696 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2019-09-09 |
4 |
S |
$7.16 |
$2,384 |
D/D |
(333) |
363 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2019-09-18 |
4 |
S |
$7.82 |
$9,197 |
D/D |
(1,176) |
1,676 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2019-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,489 |
2,852 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2020-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,135 |
14,811 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2020-02-10 |
4 |
AS |
$12.24 |
$75,886 |
D/D |
(6,199) |
8,612 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2020-03-03 |
4 |
AS |
$11.77 |
$11,660 |
D/D |
(991) |
9,719 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2020-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,098 |
10,710 |
0 |
- |
|
59 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
